RNA Therapeutics Part B

·
· Progress in Molecular Biology and Translational Science 第 204 本图书 · Elsevier
电子书
300
符合条件
评分和评价未经验证  了解详情

关于此电子书

RNA Therapeutics, Part B, Volume 204 updates on a new class of medication based on RNA molecules, with chapters on a variety of topics, including RNA therapeutics for cardiovascular disorders, RNA therapeutics for kidney injury, RNA therapeutics for beta-thalassemia, RNA therapeutics for infectious diseases, RNA therapeutics for reproductive diseases, Potential of RNA and transcriptomic data to drive drug repurposing for various diseases, RNA therapeutics for glioma/glioblastoma, RNA therapeutics for regenerative medicine, Advances in the liposome-based delivery systems for RNA therapeutics in cancer, Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics in cancer, and more. - Covers RNA therapeutics' history and future perspectives - Discusses the processes of RNA therapeutical development - Presents recent applications of RNA therapeutic in clinics - Provides the advantages and disadvantages of RNA therapeutics

作者简介

Dr. Chu is currently the Director of the Center for Biomedicine and Community Health and the Dean of the Faculty of Applied Sciences, International School, Vietnam National University (VNU), Hanoi, Vietnam. He is also a visiting Professor at the Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan. He achieved a Doctor of Veterinary Medicine degree from Vietnam in 2006, a Master of Biological Science from in South Korea in 2011. From 2011 to 2015, he participated in an EU-funded program in. Poland for the Ph.D. program in diet-induced obesity, genetic effects, and epigenetic regulations of lipid metabolism and obesity, and got a PhD in medicine (medical Biology). Dr. Chu continued his journey as a postdoc and researcher in molecumar biomoedicine under a Marie Curie Postdoctoral Research Fellowship at the Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo (Norway) from 2015 to 2018. Up to now, he has over 190 WoS/Scopus publications in biomedicne and community health with more than 21000 citations (Scopus, updated by 5/2023). He has also reviewed over 40 qualified scientific journals with more than 300 manuscripts and handed over 250 manuscripts as an editor for several WoS/Scopus journals such as Bioengineered and PLOS ONE. In 2022, the Stanford List recognized him as the Top 2% Scientists in the World.

Dr. Thai received his DVM in 2006 in Vietnam; a PhD in biomedicine in 2014 at the Faculty of Medicine, Chung-Ang University, Korea. He served as Postdoctoral Researcher and Research Professor at the Faculty of Medicine, Chung-Ang University for three consecutive years before joining the Faculty of Biotechnology, Nguyen Tat Thanh University, then Faculty of Biotechnology, Chemistry, and Environmental Engineering, Phenikaa University; and now Faculty of Applied Sciences, International School, VNU. His interest fields are included microbial epidemiology, microbial evolution, microbial immunology, gene expression, vaccine, and sub-unit vaccine. Dr. Thai has extensive working experiences with various types of microbes, including the human microbes (Rotavirus, Norovirus, Parechovirus), the animal microbes (Influenza Virus, Foot-and-Mouth Disease Virus, Infectious Bronchitis Virus), and plant microbes (Sri-Lanka Cassava Mosaic Virus, Enterobacter cloacae). His most recent research is the infection of Human Papilloma Virus (HPV) in Vietnam. This research focuses on HPV detection, HPV genotype identification, HPV vaccine evaluation. The results will provide evidence for that the HPVs remain as a reservoir of causing human papillomavirus carcinogen as well as suggesting for the development of appropriate HPV detection kit and vaccine in Vietnam.

为此电子书评分

欢迎向我们提供反馈意见。

如何阅读

智能手机和平板电脑
只要安装 AndroidiPad/iPhone 版的 Google Play 图书应用,不仅应用内容会自动与您的账号同步,还能让您随时随地在线或离线阅览图书。
笔记本电脑和台式机
您可以使用计算机的网络浏览器聆听您在 Google Play 购买的有声读物。
电子阅读器和其他设备
如果要在 Kobo 电子阅读器等电子墨水屏设备上阅读,您需要下载一个文件,并将其传输到相应设备上。若要将文件传输到受支持的电子阅读器上,请按帮助中心内的详细说明操作。